GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Other Long Term Assets

Pharmagreen Biotech (Pharmagreen Biotech) Other Long Term Assets : $0.09 Mil (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Other Long Term Assets?

Pharmagreen Biotech's other long-term assets for the quarter that ended in Jun. 2023 was $0.09 Mil.

Pharmagreen Biotech's quarterly other long-term assets increased from Dec. 2022 ($0.00 Mil) to Mar. 2023 ($0.09 Mil) and increased from Mar. 2023 ($0.09 Mil) to Jun. 2023 ($0.09 Mil).


Pharmagreen Biotech Other Long Term Assets Historical Data

The historical data trend for Pharmagreen Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Other Long Term Assets Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Other Long Term Assets
Get a 7-Day Free Trial - - - - -

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.09 0.09

Pharmagreen Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.

Pharmagreen Biotech (Pharmagreen Biotech) Headlines

From GuruFocus

PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market

By GuruFocusNews GuruFocusNews 12-20-2021

SmallCap Sentinel: A Hundred Times Better

By Marketwired Marketwired 09-27-2019